Bionovate Technologies Corp 最大收入来源是 Non-Standard Auto,在最近的收益报告中收入为 95,225,000。就地区而言, United States 是 Bionovate Technologies Corp 的主要市场,收入为 310,110,000。
Bionovate Technologies Corp 是否盈利?
不,根据最新的财务报表,Bionovate Technologies Corp 的净损失为 $0
Bionovate Technologies Corp 有负债吗?
不,Bionovate Technologies Corp 的负债为 0
Bionovate Technologies Corp 的流通股有多少?
Bionovate Technologies Corp 的总流通股为 7.75
关键数据
前收盘价
$0.0001
开盘价
$0.0001
当日区间
$0.0001 - $0.0001
52周范围
$0.0001 - $0.0001
交易量
100
平均成交量
38
股息收益率
--
每股收益(TTM)
-0.01
市值
$775.36
什么是 BIIO?
Bionovate Technologies Corp. engages in the investments and marketing of patents, and licenses which bring healthcare and lifestyle diagnostics through mobile devices. The company is headquartered in Cham, Zug and currently employs 0 full-time employees. The company went IPO on 2014-03-28. The firm is involved in the review of opportunities for merger and acquisition. The firm has no operations.